Cue Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). 

CEO
Shao Lee Lin
CEOShao Lee Lin
Employees
29
Employees29
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
29
Employees29

CUE Key Statistics

Market cap
119.04M
Market cap119.04M
Price-Earnings ratio
-5.11
Price-Earnings ratio-5.11
Dividend yield
Dividend yield
Average volume
105.17K
Average volume105.17K
High today
$29.55
High today$29.55
Low today
$27.25
Low today$27.25
Open price
$29.45
Open price$29.45
Volume
33.40K
Volume33.40K
52 Week high
$41.42
52 Week high$41.42
52 Week low
$4.97
52 Week low$4.97

Stock Snapshot

As of today, Cue Biopharma(CUE) shares are valued at $27.90. The company's market cap stands at 119.04M, with a P/E ratio of -5.11.

During the trading session on 2026-07-04, Cue Biopharma(CUE) shares reached a daily high of $29.55 and a low of $27.25. At a current price of $27.90, the stock is +2.4% higher than the low and still -5.6% under the high.

Trading activity shows a volume of 33.4K, compared to an average daily volume of 105.17K.

The stock's 52-week range extends from a low of $4.97 to a high of $41.42.

The stock's 52-week range extends from a low of $4.97 to a high of $41.42.

CUE News

Investing.com 1d
Cue Biopharma to receive $7.5 million milestone payment from Boehringer Ingelheim - Investing.com

...

Cue Biopharma to receive $7.5 million milestone payment from Boehringer Ingelheim - Investing.com

People also own

Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.